This result might imply that cDC2s prime CD4 T cells, but in this study, proliferation was examined after tumor implantation, and a role for proliferating CD4 T cells in a ‘helping’ capacity, such as for licensing cDC1s, was untested [135],. The gene discussed is CD4; the disease is neoplasm.